Yearly Publication Trends - antimalarial therapy

Relevant Publications

Pharmacovigilance in Pregnancy Studies, Exposures and Outcomes Ascertainment, and Findings from Low- and Middle-Income Countries: A Scoping Review.

Issue Release: 2024

Use of population pharmacokinetic-pharmacodynamic modelling to inform antimalarial dose optimization in infants.

Issue Release: 2024

Effect of moringa extract on parasitemia, monocyte activation and organomegaly among infected by ANKA.

Issue Release: 2024

Mesenchymal-epithelial transition and AXL inhibitor TP-0903 sensitise triple-negative breast cancer cells to the antimalarial compound, artesunate.

Issue Release: 2024

Non-immunosuppressive treatment for IgA nephropathy.

Issue Release: 2024

Myoglobin Cast Nephropathy Diagnosed on Renal Biopsy in a Patient Treated for Malarial Infection.

Issue Release: 2024

Investigating the Presence of Falsified and Poor-Quality Fixed-Dose Combination Artemether-Lumefantrine Pharmaceutical Dosage Forms in Kumasi, Ghana.

Issue Release: 2024

Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patients.

Issue Release: 2024

Reinvestigation of diphenylmethylpiperazine analogues of pyrazine as new class of cysteine protease inhibitors for the treatment of malaria.

Issue Release: 2024

Small-molecule targeting PKM2 provides a molecular basis of lactylation-dependent fibroblast-like synoviocytes proliferation inhibition against rheumatoid arthritis.

Issue Release: 2024

Clinical and immunological outcomes of HIV-exposed uninfected and HIV-unexposed uninfected children in the first 24 months of life in Western Kenya.

Issue Release: 2024

Naringin and chloroquine combination mitigates chloroquine-resistant parasite-induced malaria pathogenesis by attenuating the inflammatory response.

Issue Release: 2024

Therapeutic Targeting and Role of Cysteine Proteases in the Life Cycle of Malaria Parasite.

Issue Release: 2024

Absence of developmental and reproductive toxicity in rats, rabbits, and zebrafish embryos exposed to antimalarial drug cabamiquine.

Issue Release: 2024

SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART).

Issue Release: 2024

Oral Pyronaridine Tetraphosphate Reduces Tissue Presence of Parasites in a Mouse Model of Chagas Disease.

Issue Release: 2024

[Gastrointestinal symptoms may reflect complicated falciparum malaria].

Issue Release: 2024

Medication adherence framework: A population-based pharmacokinetic approach and its application in antimalarial treatment assessments.

Issue Release: 2024

Role of riboflavin deficiency in malaria pathophysiology.

Issue Release: 2024

Prevalence of polymorphisms in marker genes associated with antimalarial drug resistance in following 10 years of artemisinin-based combination therapy implementation in urban Kolkata.

Issue Release: 2024